CME Group: Risk Is Now The House Edge; CME Poised To Outroll Street

Group 1 - CME Group is initiated with a Strong Buy rating and a price target of $332.96, highlighting its position as a global leader in futures and options trading [1] - The company operates in an institutionalized arena where trillions in futures and options are traded, routed, and cleared daily, emphasizing its critical role in the financial markets [1] - Moretus Research focuses on identifying companies with durable business models and mispriced cash flow potential, applying a structured framework for investment analysis [1] Group 2 - Moretus Research combines rigorous fundamental analysis with a judgment-driven process, aiming to provide clarity and actionable insights for serious investors [1] - The research emphasizes comparability, simplicity, and relevance in valuation, tailored to each company's business model and capital structure [1] - The coverage tends to favor underappreciated companies undergoing structural changes or temporary dislocations, where disciplined analysis can lead to asymmetric returns [1]